Biggest News Aggregation in the World
📰 Program To News

Program To News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Program To. Real-time updates on events, politics, business and more.

New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis

Following four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10 patients for Psoriasis Area and Severity Index 75 in the POETYK PSO long-term...
United States Alyssa Johnsen April Armstrong Los Angeles Bristol Myers Squibb Laboratory Abnormalities

After rejecting compromise, Speaker Johnson again demands border bill as condition for Ukraine aid

Here we go again. As the Senate worked furiously over the last several days to bring a $95 billion aid bill for Ukraine, Israel, and Taiwan across the finish line, a minority of Republicans, at the urging of former President Donald Trump and led by House Speaker Mike Johnson (R-LA), have been working just as hard to block any additional aid to Ukraine
Israel General United States Red Sea Djibouti General Bruxelles Capitale North Korea

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sotyktu (deucravacitinib) Long-Term Data Demonstrate Durable Efficacy and Consistent Safety for up t

Clinical response was maintained at 73.2% for Psoriasis Area and Severity Index (PASI) 75 with three years of continuous Sotyktu treatment in the POETYK PSO long-term extension trialSotyktu demonstrated a consistent safety profile with no increases in adverse events or serious adverse events and no emergence of any...
United States April Armstrong Bristol Myers Squibb Los Angeles Roland Chen Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science